Titan Pharmaceuticals (TTNP) Competitors

Titan Pharmaceuticals (NASDAQ:TTNP) and BioCardia (NASDAQ:BCDA) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their community ranking, analyst recommendations, valuation, profitability, media sentiment, risk, dividends, earnings and institutional ownership.

Do analysts recommend TTNP or BCDA?

BioCardia has a consensus price target of $25.00, suggesting a potential upside of 1,156.28%. Given BioCardia's stronger consensus rating and higher possible upside, analysts plainly believe BioCardia is more favorable than Titan Pharmaceuticals.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Titan Pharmaceuticals	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
BioCardia	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

Do insiders & institutionals believe in TTNP or BCDA?

31.5% of Titan Pharmaceuticals shares are owned by institutional investors. Comparatively, 20.6% of BioCardia shares are owned by institutional investors. 24.9% of Titan Pharmaceuticals shares are owned by insiders. Comparatively, 20.0% of BioCardia shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Is TTNP or BCDA more profitable?

Titan Pharmaceuticals has a net margin of 0.00% compared to BioCardia's net margin of -1,999.77%. BioCardia's return on equity of 0.00% beat Titan Pharmaceuticals' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Titan Pharmaceuticals	N/A	-87.90%	-75.11%
BioCardia	-1,999.77%	N/A	-208.38%

Does the MarketBeat Community prefer TTNP or BCDA?

Titan Pharmaceuticals received 320 more outperform votes than BioCardia when rated by MarketBeat users. However, 57.69% of users gave BioCardia an outperform vote while only 54.83% of users gave Titan Pharmaceuticals an outperform vote.

Company	Underperform	Outperform
Titan Pharmaceuticals	Outperform Votes 335 54.83%	Underperform Votes 276 45.17%
BioCardia	Outperform Votes 15 57.69%	Underperform Votes 11 42.31%

Does the media refer more to TTNP or BCDA?

In the previous week, BioCardia had 9 more articles in the media than Titan Pharmaceuticals. MarketBeat recorded 10 mentions for BioCardia and 1 mentions for Titan Pharmaceuticals. BioCardia's average media sentiment score of 0.81 beat Titan Pharmaceuticals' score of 0.00 indicating that BioCardia is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Titan Pharmaceuticals	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
BioCardia	1 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has preferable earnings & valuation, TTNP or BCDA?

Titan Pharmaceuticals has higher revenue and earnings than BioCardia.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Titan Pharmaceuticals	$180K	18.58	-$5.57M	N/A	N/A
BioCardia	$71K	59.53	-$11.57M	-$4.19	-0.47

Which has more volatility & risk, TTNP or BCDA?

Titan Pharmaceuticals has a beta of 1.12, indicating that its share price is 12% more volatile than the S&P 500. Comparatively, BioCardia has a beta of 1.28, indicating that its share price is 28% more volatile than the S&P 500.

Summary

BioCardia beats Titan Pharmaceuticals on 9 of the 16 factors compared between the two stocks.